Fmr LLC Verona Pharma PLC Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Fmr LLC holds 719,691 shares of VRNA stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

719,691

Previous 1,731,353 58.43%

Holding current value

$21 Million

Previous $27.9 Million 62.64%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$11.48 - $17.02 $11.6 Million - $17.2 Million	-1,011,662 Reduced 58.43%	719,691 $10.4 Million
Q1 2024 May 13, 2024	SELL	$15.3 - $20.24 $48.5 Million - $64.2 Million	-3,171,024 Reduced 64.68%	1,731,353 $27.9 Million
Q4 2023 Feb 13, 2024	SELL	$11.94 - $20.47 $24.5 Million - $42.1 Million	-2,055,581 Reduced 29.54%	4,902,377 $97.5 Million
Q3 2023 Nov 13, 2023	SELL	$16.3 - $22.09 $2.47 Million - $3.35 Million	-151,812 Reduced 2.14%	6,957,958 $113 Million
Q2 2023 Aug 11, 2023	BUY	$19.41 - $23.43 $49.4 Million - $59.6 Million	2,542,591 Added 55.67%	7,109,770 $150 Million
Q1 2023 May 11, 2023	BUY	$18.06 - $25.27 $43.2 Million - $60.5 Million	2,393,033 Added 110.07%	4,567,179 $91.7 Million
Q4 2022 Feb 13, 2023	BUY	$9.84 - $26.13 $17.3 Million - $46 Million	1,760,746 Added 425.92%	2,174,146 $56.8 Million
Q3 2022 Nov 10, 2022	BUY	$4.14 - $13.59 $1.71 Million - $5.62 Million	413,400 New	413,400 $4.23 Million

Others Institutions Holding VRNA

# of Institutions

137

Shares Held

66.7M

Call Options Held

495K

Put Options Held

486K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $1.78B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account